Correlates of broadly neutralizing antibody developmentAbela, Irene A.a; Kadelka, Clausb; Trkola, AlexandraaCurrent Opinion in HIV and AIDS: July 2019 - Volume 14 - Issue 4 - p 279–285 doi: 10.1097/COH.0000000000000552 BROAD NEUTRALISING AND NON-NEUTRALISING ANTIBODIES: Edited by Hugo Mouquet and Olivier Schwartz Buy Abstract Author InformationAuthors Article MetricsMetrics Purpose of review Broadly neutralizing antibodies (bnAbs) are considered a key component of an effective HIV-1 vaccine, but despite intensive efforts, induction of bnAbs by vaccination has thus far not been possible. Potent bnAb activity is rare in natural infection and a deeper understanding of factors that promote or limit bnAb evolution is critical to guide bnAb vaccine development. This review reflects on recent key discoveries on correlates of bnAb development and discusses what further insights are needed to move forward. Recent findings An increasing number of parameters have been implicated to influence bnAb development in natural infection. Most recent findings highlight a range of immune factors linked with bnAb evolution. Novel approaches have brought exciting progress in defining signatures of the viral envelope associated with bnAb activity. Summary Focused efforts of recent years have unraveled a multiply layered process of HIV-1 bnAb development. As it is understood today, bnAb evolution can be triggered and influenced by a range of factors and several different pathways may exist how bnAb induction and maturation can occur. To capitalize on the gained knowledge, future research needs to validate factors to identify independent drivers of bnAb induction to advance vaccine design. aInstitute of Medical Virology, University of Zurich, Zurich, Switzerland bDepartment of Mathematics, Iowa State University, Ames, Iowa, USA Correspondence to Alexandra Trkola, PhD, Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland. Tel: +41 44 634 53 80; e-mail: email@example.com Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.